ARIAD Pharmaceuticals (ARIA)
|
19.60
-0.20 (-1.01%)
|
|
|
|
ARIA additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ARIA Profile
•
Exchange
NASDAQ
•
Top Holders (By Fund)
Vanguard Small Cap Index Inv
Vanguard Small Cap Index Adm
Vanguard Small Cap Index Signal
Vanguard Small Cap Index I
Vanguard Small Cap Growth Index Inv
Vanguard Small Cap Growth Index I
Prudential Jennison Health Sciences A
Prudential Jennison Health Sciences C
Prudential Jennison Health Sciences B
Prudential Jennison Health Sciences Z
Vanguard Small Cap Index Adm
Vanguard Small Cap Index Signal
Vanguard Small Cap Index I
Vanguard Small Cap Growth Index Inv
Vanguard Small Cap Growth Index I
Prudential Jennison Health Sciences A
Prudential Jennison Health Sciences C
Prudential Jennison Health Sciences B
Prudential Jennison Health Sciences Z
•
Top Holders (By Family)
•
Executives
Dr. Harvey J. Berger M.D.
Principal Founder
Chairman Chief Exec. Officer Pres and Chairman of Exec. Committee
Mr. Edward M. Fitzgerald
Chief Financial Officer
Principal Accounting Officer Exec. VP and Treasurer
Dr. Frank G. Haluska M.D. .D.
53
Chief Medical Officer and Sr. VP of Clinical R&D
Mr. Martin J. Duvall
Sr. VP of Commercial Operations
Dr. Timothy P. Clackson Ph.D.
Chief Scientific Officer and Pres of R&D
Principal Founder
Chairman Chief Exec. Officer Pres and Chairman of Exec. Committee
Mr. Edward M. Fitzgerald
Chief Financial Officer
Principal Accounting Officer Exec. VP and Treasurer
Dr. Frank G. Haluska M.D. .D.
53
Chief Medical Officer and Sr. VP of Clinical R&D
Mr. Martin J. Duvall
Sr. VP of Commercial Operations
Dr. Timothy P. Clackson Ph.D.
Chief Scientific Officer and Pres of R&D
•
Employee Count
150
Special Offers
Competitors
ARIA earnings
Date
Actual
Expected
Prev Yr Qtr
11/7/2012
-0.32
-0.32
0.10
8/2/2012
-0.31
-0.27
-0.36
5/9/2012
-0.35
-0.26
-0.29
